Generic Viibryd Reviews

0 views

Skip to first unread message

Serafin Sonnier

unread,

Aug 3, 2024, 3:51:05 PM8/3/24

to gavaporra

Special authorization is a mechanism to provide access to certain drugs according to defined clinical criteria. Special authorization request forms are completed by physicians and reviewed by clinical pharmacists. Prior approval must be granted to ensure coverage by special authorization.

The least cost alternative price is the lowest cost medication in an interchangeable (generic) drug grouping. Generic drugs have the same therapeutic effectiveness as the other drug products in the interchangeable grouping.

Alberta's supplementary health plans will pay for the lowest priced drug product where interchangeable products can be used to fill a prescription. Beneficiaries who choose higher cost alternatives are responsible for paying the difference in price.

Alberta is a participant in the national Common Drug Review. The Common Drug Review (CDR) is a single process for reviewing new drugs and providing listing recommendations to participating publicly funded drug benefit plans in Canada. The CDR consists of:

Alberta's Expert Committee on Drug Evaluation and Therapeutics (ECDET) also reviews drug products and provides advice and recommendations to the Minister of Health concerning the therapeutic value and cost-effectiveness of the drugs.

If there is a need to reconsider drugs not initially approved through the drug review process, the Ministry of Health has a process where drugs not listed through the CEDAC and ECDET review processes may be reconsidered for coverage, known as product listing agreements.